(Press-News.org) WHAT:
A first-in-human clinical trial of an experimental oral drug for removing radioactive contaminants from inside the body has begun. The trial is testing the safety, tolerability and processing in the body of escalating doses of the investigational drug product HOPO 14-1 in healthy adults. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is funding the Phase 1 trial, which is sponsored and conducted by SRI International of Menlo Park, California.
Internal radioactive contamination occurs when radioactive elements are absorbed through wounded skin, inhaled or ingested. This could happen as the result of a nuclear power plant accident or the detonation of a “dirty bomb” or nuclear weapon. As the atoms of radioactive elements decay, they emit ionizing radiation, which can damage DNA, tissues and organs. One method for reducing the risk of this damage is to remove the radioactive elements from the body as soon as possible after contamination occurs.
The Food and Drug Administration has approved two products for removing internal radioactive contamination. These drugs, both based on diethylenetriamine pentaacetate (DTPA), are administered intravenously by a healthcare provider and can remove three radioactive elements: plutonium, americium, and curium.
In contrast, HOPO 14-1 has been formulated as an oral capsule, which would be easier than an intravenous drug to stockpile and to deploy and administer during an emergency. Preclinical research has shown that HOPO 14-1 can effectively remove many radioactive contaminants, including uranium and neptunium in addition to plutonium, americium and curium. These studies also have found that HOPO 14-1 is up to 100 times more effective than DTPA at binding and removing these radioactive elements.
NIAID has funded the discovery and development of HOPO 14-1 since 2006. The active pharmaceutical ingredient in the drug is called 3,4,3-LI(1,2-HOPO).
The clinical trial is taking place at a site in Plymouth, Michigan, under the leadership of Sascha N. Goonewardena, M.D., a physician investigator at SRI’s Clinical Trials Unit and an assistant professor of medicine at the University of Michigan Medical School in Ann Arbor. The study team will enroll 42 healthy participants ages 18 to 65 years in seven groups of six. Each participant in the first group will receive a 100-milligram (mg) dose of HOPO 14-1. The subsequent groups will receive increasingly higher doses of the study drug up to 7500 mg in the final group, if lower doses are deemed safe. Participants will undergo intensive safety monitoring and will be followed for 14 days to measure the absorption, distribution and elimination of the study drug. Results are expected in 2024.
Additional information about the trial is available in ClinicalTrials.gov under study identifier NCT05628961.
WHO:
Andrea DiCarlo-Cohen, Ph.D., director of the Radiation and Nuclear Countermeasures Program in the NIAID Division of Allergy, Immunology and Transplantation, is available to respond to media inquiries about the trial.
CONTACT:
To schedule interviews, please contact Laura Leifman, (301) 402-1663, NIAIDNews@niaid.nih.gov.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.
NIH...Turning Discovery Into Health®
END
Clam leases are designated underwater locations used to produce hard clams of all sizes from littlenecks to chowders. Clam production or aquaculture can be a risky business due in part to unwanted marine intruders. Among them, stealthy and highly mobile rays.
The Indian River Lagoon is one key location used for hard clam (Mercenaria mercenaria) aquaculture operations along Florida’s Atlantic coast. Clam fishermen have anecdotally reported seeing rays in clam leases and suspect that their interactions could result in damaged aquaculture gear and crushed clams. After all, ...
CAPE COD, MASSACHUSETTS – Earlier this year, the US Environmental Protection Agency proposed maximum allowable levels in drinking water for six PFAS (per- and polyfluoroalkyl substances) – so-called forever chemicals. But the draft standards do not account for half of the PFAS at contaminated sites across the country.
The findings are from a team led by the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) and are published in the journal Environmental Science & Technology.
PFAS are present in fire retardant foams ...
Embargoed for release: Monday, May 15, 2023, 8:00 AM ET
Boston, MA – People who live in communities with higher proportions of Black and Hispanic/Latino residents are more likely to be exposed to harmful levels of per- and polyfluoroalkyl substances (PFAS) in their water supplies than people living in other communities, according to a new study led by researchers from Harvard T.H. Chan School of Public Health. The researchers link this finding to the disproportionate siting of sources of PFAS pollution—such ...
WINSTON-SALEM, NC – MAY 15, 2023 – The Wake Forest Institute for Regenerative Medicine (WFIRM) will make history this month when the first bioprinted solid tissue constructs soar to the International Space Station (ISS) on board the next all private astronaut mission by commercial space leader Axiom Space.
The Axiom Mission 2 (Ax-2) launch by Houston-based Axiom Space is launching from Florida’s Kennedy Space Center. The crew will conduct extensive scientific research experiments including WFIRM’s vascularized tissue research – which won first place in the NASA Vascular Tissue Challenge in 2021.
Liver ...
While a visit to the great outdoors is a common prescription for reducing screen use, a pioneering new study finds that time outdoors doesn’t always reduce smartphone screentime.
The new research, which tracked smartphone activity of 700 study participants for two years, reveals that participants’ smartphone activity actually increased during visits to city parks and other urban green spaces.
With smartphone use rising worldwide, the study clearly identifies a powerful way to reduce screen time: participants who visited nature reserves or forests saw significant declines in screentime over the first three hours, ...
BALTIMORE, Md. (May 15, 2023) – More than 100 genes linked to the risk of schizophrenia seem to cause illness because of their role in the placenta rather than in the developing brain, according to a new study led by the Lieber Institute for Brain Development.
Scientists had generally assumed for over a century that genes for schizophrenia risk were principally, if not exclusively, about the brain. But the latest research, just published in Nature Communications, found that the placenta plays a much more significant role in developing illness than previously known.
“The secret of the genetics of schizophrenia has been hiding in plain ...
Statement Highlights:
In a review of the latest research, few stroke studies addressed racist policies, such as residential segregation, or social determinants of health, such as neighborhood deprivation, walkability or security; food availability; economic stability; education quality; or employment and health insurance, all of which play a role in stroke incidence, care and outcomes.
The statement summarizes research on interventions to address racial and ethnic disparities in stroke care and outcomes.
Additional research is needed to determine ...
The light pollution caused by coastal cities can trick coral reefs into spawning outside of the optimum times when they would normally reproduce, a new study has found.
Coral broadcast spawning events – in which lunar cycles trigger the release of eggs on certain nights of the year – are critical to the maintenance and recovery of reefs following mass bleaching and other similar events.
However, using a combination of light pollution data and spawning observations, researchers were able to show for the first time that ...
LA JOLLA, CALIF. – May 15, 2023 – Researchers from Sanford Burnham Prebys and the Chinese University of Hong Kong have developed a computational approach to predict whether a person with type 2 diabetes will develop kidney disease, a frequent and dangerous complication of diabetes. Their results, published in Nature Communications, could help doctors prevent or better manage kidney disease in people with type 2 diabetes.
“This study provides a glimpse into the powerful future of predictive diagnostics,” says co-senior author Kevin Yip, Ph.D., a professor and director of Bioinformatics ...
Cribs, strollers and other infant and child equipment can be expensive and most families in a new national poll agree that it’s wasteful to buy these items new when they’re needed for such a short time.
But while half of parents say they have used pre-owned equipment for babies and young children, two in three acknowledge that it’s difficult to always know whether it’s safe for their child, according to the University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health.
“Used child essentials ...
